Vitekta

국가: 뉴질랜드

언어: 영어

출처: Medsafe (Medicines Safety Authority)

유효 성분:

Elvitegravir 150mg;  ;  ;  ;  

제공처:

Gilead Sciences (NZ)

INN (International Name):

Elvitegravir 150 mg

복용량:

150 mg

약제 형태:

Film coated tablet

구성:

Active: Elvitegravir 150mg         Excipient: Croscarmellose sodium Hyprolose Lactose monohydrate Magnesium stearate Microcrystalline cellulose Opadry green 85F91203 Sodium laurilsulfate

처방전 유형:

Prescription

Manufactured by:

Catalent Micron Technologies Inc

치료 징후:

Indicated for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults and adolescents when co-administered with a ritonavir-boosted protease inhibitor and other antiretroviral therapy.

제품 요약:

Package - Contents - Shelf Life: Bottle, plastic, HDPE with child resistant PE cap - 30 tablets - 24 months from date of manufacture stored at or below 25°C

승인 날짜:

2013-11-04